SLC7A11 and cancer: Sulfasalazine markedly reduced the intracellular content of both cysteine and GSH in both OSC19 and HSC-4 cells (Figure 1B), suggesting that cancer cells that manifest resistance to xCT inhibition might rely on a ROS defense system other than that mediated by cysteine and GSH.